{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:17:30Z","timestamp":1791145050329,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":4937,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.exphem.2008.07.013","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T04:24:48Z","timestamp":1223267088000},"page":"1642-1647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Proteomic study of the impact of the JAK2\u2013V617F mutation on the phenotype of essential thrombocythemia"],"prefix":"10.1016","volume":"36","author":[{"given":"Pascal","family":"Mossuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Arlotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Hermouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bouamrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lippert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Girodon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ir\u00e8ne","family":"Dobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praloran","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Yves","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2008.07.013_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc2210","article-title":"Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine","year":"2007","journal-title":"Nat Rev"},{"key":"10.1016\/j.exphem.2008.07.013_bib2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythemia and relation to polycythemia vera based on JAK2\u2013V617F mutation status: a prospective study","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2008.07.013_bib3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2006-12-064287","article-title":"Clinical profile of homozygous JAK2V6127F mutation in patients with polycythemia vera or essential thrombocythemia","volume":"110","author":"Vannucchi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.07.013_bib4","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/cncr.22663","article-title":"Clinical correlates of JAK2V617F allele burden in essential thrombocythemia","volume":"109","author":"Kittur","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2008.07.013_bib5","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2006-01-013540","article-title":"The JAK2\u2013V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera","volume":"108","author":"Lippert","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.07.013_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3324\/haematol.11653","article-title":"Influence of JAK2V6127F allele burden on phenotype in essentiel thrombocythemia","volume":"93","author":"Antonioli","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2008.07.013_bib7","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/pmic.200402053","article-title":"Recent advances in blood related proteomics","volume":"5","author":"Thadikkaran","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.exphem.2008.07.013_bib8","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.leu.2403897","article-title":"Proteomic analysis of childhood leukaemia","volume":"19","author":"Hegedus","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2008.07.013_bib9","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/pmic.200500647","article-title":"Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers","volume":"6","author":"Cussac","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.exphem.2008.07.013_bib10","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1073\/pnas.0502825102","article-title":"Systems analysis of transcriptome and proteome in retinoic acid\/arsenic trioxide\u2013induced cell differentiation\/apopotosis of promyelocytic leukemia","volume":"102","author":"Zheng","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.exphem.2008.07.013_bib11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/cncr.21770","article-title":"Proteomic\u2013based prediction of clinical behaviour in adult acute lymphoblastic leukaemia","volume":"106","author":"Albitar","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2008.07.013_bib12","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1158\/1078-0432.CCR-04-0307","article-title":"Proteomic analysis of human leukemia cells: insight into their classification","volume":"10","author":"Cui","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2008.07.013_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hep.20505","article-title":"Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases","volume":"41","author":"Paradis","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.exphem.2008.07.013_bib14","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1158\/0008-5472.CAN-04-0746","article-title":"Three biomarkers identified from serum proteomic analysis for the detection of early stage of ovarian cancer","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2008.07.013_bib15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.exphem.2004.06.006","article-title":"The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia","volume":"32","author":"Kwak","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2008.07.013_bib16","first-page":"1194","article-title":"Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis","volume":"89","author":"Mossuz","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2008.07.013_bib17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/prca.200601051","article-title":"Apolipoprotein A1: A new serum marker correlated to JAK2\u2013V617F proportion at diagnosis in patients with polycythemia vera","volume":"1","author":"Mossuz","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.exphem.2008.07.013_bib18","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-06-2210","article-title":"Characterization of murine JAK2V6127F positive myeloproliferative disease","volume":"66","author":"Bumm","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2008.07.013_bib19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2\u2013V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.07.013_bib20","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2007-08-107748","article-title":"Ratio of mutant JAK2\u2013V617F to wild type Jak2 determines the MPD phenotypes in transgenic mice","volume":"111","author":"Tiedt","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.07.013_bib21","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2006-04-018259","article-title":"Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not n essential thrombocythemia","volume":"108","author":"Scott","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.07.013_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/518809","article-title":"Highly sensitive method for\u00a0genome wide detection of allelic composition in non\u2013paired, primary tumor specimens by use of affymetrix single nucleotide\u2013polymorphism genotyping microarrays","volume":"81","author":"Yamamoto","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.exphem.2008.07.013_bib23","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2006-03-008227","article-title":"The JAK2\u2013V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)","volume":"108","author":"Boissinot","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.07.013_bib24","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood-2006-05-021527","article-title":"Latent myeloproliferative disorder revealed by the JAK2\u2013V617F mutation in patients with splanchnic vein thrombosis and normal or low hematocrit and platelet counts","volume":"108","author":"Boissinot","year":"2006","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X08003901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X08003901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:27:04Z","timestamp":1759566424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X08003901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0301472X08003901"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2008.07.013","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic study of the impact of the JAK2\u2013V617F mutation on the phenotype of essential thrombocythemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2008.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}